Algernon Pharmaceuticals: Advancing DMT into a Phase 1 Clinical Trial, CEO Clips Video

Error message

Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2022) - Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) The company is focused on the disease area of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.

Metadata

Provider:

Newsfile

Retrieved on:

Tuesday, November 8, 2022

Information

Tags:

CSE, Chronic kidney disease, Chronic cough, Idiopathic pulmonary fibrosis, IPF, DMT, Trial of the century, Stroke, AGN, Pharmaceutical industry, Amusement arcade

Geotags:

VANCOUVER, BRITISH COLUMBIA

Organisation:

CEO CLIPS

Stock Symbol:

OTCQB:AGNPF

CNSX:AGN

Summary

Key Points:

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2022) - Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) The company is focused on the disease area of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease.
Algernon was recently granted permission to conduct a Phase 1 clinical study of DMT for the treatment of stroke.
If you cannot view the video above, please visit:

Vancouver, British Columbia--(Newsfile Corp. - November 8, 2022) - Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF) – The company is focused on the disease area of stroke, idiopathic pulmonary fibrosis (IPF) & chronic cough, and chronic kidney disease. Algernon was recently granted permission to conduct a Phase 1 clinical study of DMT for the treatment of stroke.

If you cannot view the video above, please visit:
https://www.b-tv.com/post/cse-agn-algernon-pharmaceuticals-advancing-dmt-into-a-phase-1-clinical-trial-btv-ceo-clips-60sec

Algernon Pharmaceuticals (CSE: AGN) (OTCQB: AGNPF)

https://algernonpharmaceuticals.com/

About CEO Clips:

CEO Clips – are short company video profiles broadcast to a large audience of investors on TV and 15+ financial sites including Reuters, Yahoo!Finance, and Wall Street Journal.

BTV – Business Television/CEO Clips

Discover Companies to Invest in

www.b-tv.com

Contact: Trina Schlingmann (604) 664-7401 x 5 [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/143122